Does TACROLIMUS Cause Squamous cell carcinoma? 327 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 327 reports of Squamous cell carcinoma have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.4% of all adverse event reports for TACROLIMUS.
327
Reports of Squamous cell carcinoma with TACROLIMUS
0.4%
of all TACROLIMUS reports
53
Deaths
72
Hospitalizations
How Dangerous Is Squamous cell carcinoma From TACROLIMUS?
Of the 327 reports, 53 (16.2%) resulted in death, 72 (22.0%) required hospitalization, and 31 (9.5%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 327 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
USTEKINUMAB (246)
Which TACROLIMUS Alternatives Have Lower Squamous cell carcinoma Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB